Texas Oncology, P.A. is a clinical research site located in Dallas, Texas, United States.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology, P.A. has participated in 49 clinical trials with 8 currently active.
Therapeutic areas: Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, Prostate Cancer, Rectal Cancer.
Sponsors: Biogen, US Oncology Research, Bristol-Myers Squibb.
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology, P.A. has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology, P.A. has 49 clinical trials on record, with 8 currently active. Their work covers Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, Prostate Cancer, Rectal Cancer.
Yes — Texas Oncology, P.A. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.